Objectives: To present an uncommon cause for a submandibular mass and review of the literature.
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CASE REPORTS

CASE REPORT
A 25-year-old lady presented to the Otorhinolaryngology clinic of RIPAS Hospital, Bandar Seri Begawan, Negara Brunei Darussalam with a large painless right submandibular swelling which had grown very slowly over a 6-year period. The submandibular mass was non-inflammatory, non-pulsatile, non-tender, lobulated and soft in consistency measuring approximately 4x4 cm in dimension. It exhibited an element of mobility with respect to the adjacent mandible with no fixation to the overlying skin. There were no palpable neck nodes and minimal movement on tongue protrusion. There were no significant ear, nose or throat findings on clinical examination. (Figure 1) revealed fibro-vascular tissue containing large numbers of prominent endothelial lined capillaries along with a moderate number of veins around the lesion. (Figure 3) A proportion of the cells showed intracytoplasmic lumina with the pleomorphic nuclei. (Figure 4 ) Tumor cells stained for CD 34. However, S100 was negative. Reticulin stain highlighted the vascular nature of the tumor. The appearance was consistent with EHE. 
(Hematoxylin and Eosin, 40X)
An arterial phase CT scan of the neck was performed which revealed a 4 x 2.9 cm well-defined avidly enhancing mass in the right submandibular space with the vascular supply from an engorged retromandibular vein and facial artery lying on the medial aspect of the mass. Immediately adjacent to the mass on the anteromedial aspect was an apparent separate identical 1.1cm lesion recruiting its vascular supply from the right lingual artery. In view of histopathological diagnosis, CT of the chest and abdomen was performed for staging purposes but was negative.
Pre-operative catheter angiography and embolization was performed 24 hours prior to surgery which revealed a vascular mass in the right submandibular region being supplied by a large feeder vessel from the lingual branch of the facial artery. (Figure 5 ) This was embolized with Surgicel. Wide local excision of the tumor was performed under general anesthesia via a horizontal curvilinear incision, 4 cm inferior to the horizontal lower border of mandible. Sub-platysmal wide dissection around the tumor mass was undertaken. The arterial branch from the facial artery and a feeding vessel from the deeper surface of the gland were ligated and divided. The venous branches were electro-cauterized. The tumor mass was anatomically located in the right submandibular region with the mylohyoid muscle and the right anterior belly of digastric muscle forming the surgical floor of the resected mass. It was distinct from the submandibular salivary gland located posteriorly. The excised surgical specimen was 6 X 4 X 2.5 cm in dimension. (Figure 6 )
The right marginal mandibular nerve function was intact postoperatively. A vacuum lantern drain was placed for 48 hours.
Histopathology of the resected specimen revealed a tumor consisting of thin walled capillaries arranged in a lobular pattern situated in a hyalinized stroma. It contained prominent endothelial cells with eosinophilic cytoplasm and hyperchromatic, pleomorphic nuclei with indistinct nucleoli. There were 2-3 mitotic figures per 10 high power field. The margins were free of the tumor. The findings were consistent with EHE. DISCUSSION EHE has been documented to occur at several anatomical sites such as the liver, lung, pleura, bone, lymph nodes, skin, brain, meninges and heart. EHE in the head and neck has been found to originate from the soft tissues with approximately 26% of cases exhibiting re-absorption and / or adjacent bone destruction. Tongue and gingival ridges are the most common sites of origin in the oral cavity with the upper gingivae and oral mucosa being the most common sites of relapse. Lesions in the nasal cavity, parotid gland, larynx and thyroid have also been reported. 6 In our case, there was no evidence of adjacent soft tissue or bone involvement. EHE has no age or sex predisposition. It is rare in children. 6, 7 These lesions are generally asymptomatic, painless and present as illdefined solitary masses in the superficial or deep soft tissues. Enzinger and Weiss considered the biological behavior of EHE to be between a hemangioma and angiosarcoma. 1 The World Health Organization (WHO) has classified EHE as a malignant vascular soft tissue tumor. 8 EHE has been reported to have a high rate of metastasis (20-30%) and mortality (10-20%) when it affects the soft tissues and viscera. 6 Deyrup et al. analyzed 49 cases of EHE in soft tissues and concluded that large tumors (Diameter > 3cm) with high mitotic activity ( > 3 mitotic figures / 50 HPF) have an aggressive clinical course. 9 EHE has several morphological characteristics that are similar to carcinomas, melanomas and epitheloid sarcomas. 10 Immunohistochemistry provides reliable clues regarding differentiation.
Some surgeons advocate pre-operative embolization in order to prevent excessive intra-operative hemorrhage. 11 In our case, radiological evaluation with Doppler ultrasonography and contrast-enhanced CT was helpful in assessing the vascularity and pre-operative angiography Figure 6 . Excised tumor -gross specimen measuring 6x4x2.5 cm with suture marking on its superiormedial aspect followed by embolization led to a relatively bloodless surgical excision.
The recommended treatment for EHE consists of a wide local excision with regional lymph node resection due to the high risk of lymphatic metastases. 12, 13 However, there are no established standard therapeutic protocols for this disease due to its rarity. Therefore an individual caseby-case approach and follow-up needs to be undertaken. Unresectable invasive EHE may be subjected to radiotherapy.
14 Anti-angiogenic agents have been proposed as a possible future treatment option.
